ims class assignment
TRANSCRIPT
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 1/19
Data. Insights. Results.
1
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 2/19
2
PRESENTATION FOR
MARKETING RESEARCH
COMPANY.
Submitted to:
Dr.Wafaa Marzouk
Done by:
Mohamed Kadri & Ahmed Mahdy.
22 Feb 2009
ASSIGNMENT DESCRIPTION
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 3/19
3
Intercontinental Marketing Services
Pharmaceutical companies face extraordinary
competition for market share and pressures to
maximize brand lifecycles, all while proving the
value of their medicines.
IMS can apply insight and capabilities to a
tremendously rich set of data assets and analytics.
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 4/19
4
IMS HISTORY
Back in 1954, Bill Frohlich, an advertising executive,
and David Dubow, a visionary, set out to create anew kind of information company that could enable
organizations to make informed, strategic decisions
about the marketplace. They called their venture
Intercontinental Marketing Services.
IMS today is recognized as the leader in its field — the world’s leading provider of market intelligence to
the pharmaceutical and healthcare industries.
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 5/19
5
Strategy: Innovation Drives Growth
By 1957, IMS had published its first European
syndicated research study, an audit of
pharmaceutical sales within the West German
market. Its utility and popularity prompted IMS
to expand into new geographies— Great
Britain, France, Italy, Spain, and Japan among
them. Subsequent acquisitions in South Africa,
Australia, and New Zealand strengthened theIMS position, and by 1969, IMS, with an annual
revenue of $5 million, had established the gold
standard in pharmaceutical market research in
Europe and Asia.
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 6/19
6
Strategy: Innovation Drives Growth
By 1981, IMS was a thriving worldwide company with
offices in 57 countries and annual revenues of $170
million.
It was also a company at a crossroads — a company that
soon elected to reestablish itself as a company solely
focused on healthcare by shedding its consumer researchinterests.
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 7/19
60% Non–USRevenues
Operate in Over100 Countries
Over 1 Million DrugProducts Tracked
Over 2,500 PharmaManufacturersSupported
Global Leadershipfor 50 Years
Our Profile . . .
Our Profile...
7
225,000Data Sources
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 8/19
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 9/19
9
IMS Scope
At IMS,it works with nearly every major
pharmaceutical and biotech company in the
world on projects ranging from portfolio
development to product lifecycle management.
It also provide information, analytics and
consulting to a growing range of other
organizations with a stake in global healthcare.
They also have an internet service(59website).
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 10/19
1997 2001 2006
N. America Europe Japan Other
$387B
$618B
$296B
10
Pharma Industry Growth
1997-2006
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 11/19
GlobalExecution
Marketing
Pharmaceutical Industry Challenges
Sales
ThePipeline
Managing the Life Cycle& New Drugs Drive Growth.
Maximize Revenue from Portfolio
Transformation& Productivity of Representative.
A More Complex Mix.
Unique Tactics & Speed.
Pharmaceutical Challenges
11
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 12/19
12
These trends help drive our strategy . . .
Opportunities for IMS
More Solutions to Optimize Sales.
More Detailed and Precise Data, New Data.
More Integration of All Information Sources.
More Customization of Applications.
More Diverse Users Need to be Served.
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 13/19
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 14/19
Integrated Applications
Consulting
Data
14
IMS Territory Planner
“How am I doing against the competition?”
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 15/19
Integrated Applications
Consulting
Data
15
IMS Territory Planner
“How effective are my calls?”
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 16/19
Integrated Applications
Consulting
Data
16
IMS Strategy Evaluator
Random targeting
% of potential sales
increase
Perfect targeting
0%
20%
40%
60%
80%
100%
Usual targeting
conducted by majority of
pharmaceutical
companies
0% 20% 40% 60% 80% 100%
% customers visited
Opportunity
Illustrative Example
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 17/19
17
IMS Core Strengths
People
Reputation of Leadership and Innovation.
Customer Base.
Unmatched Data Assets and Expertise.
Solutions.
Global Coverage.
Financial Model.
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 18/19
18
IMS Egypt
8, Khaled Ibn El Walid St.
Sheraton Area, Helipolis
Cairo
Egypt
Tel: +20 (2) 22 66 17
IMS HEADQUARTER,EGYPT
Corporate Headquarters
901 Main Avenue
Suite 612
Norwalk, CT 06851-1187
USA
Tel: 1 (203) 845-5200Sales &
Marketing
7/28/2019 IMS Class Assignment
http://slidepdf.com/reader/full/ims-class-assignment 19/19
© 2002 IMS Health Incorporated or its affiliates. All ri ghts reserved.19